IBDEI0VK ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15609,0)
 ;;=582.1^^95^951^12
 ;;^UTILITY(U,$J,358.3,15609,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15609,1,3,0)
 ;;=3^582.1
 ;;^UTILITY(U,$J,358.3,15609,1,4,0)
 ;;=4^NEPHRITIS,CHR MEMBRANOUS
 ;;^UTILITY(U,$J,358.3,15609,2)
 ;;=^24388
 ;;^UTILITY(U,$J,358.3,15610,0)
 ;;=582.2^^95^951^11
 ;;^UTILITY(U,$J,358.3,15610,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15610,1,3,0)
 ;;=3^582.2
 ;;^UTILITY(U,$J,358.3,15610,1,4,0)
 ;;=4^NEPHRITIS,CHR MEMBRANOPROLIF
 ;;^UTILITY(U,$J,358.3,15610,2)
 ;;=^24386
 ;;^UTILITY(U,$J,358.3,15611,0)
 ;;=582.4^^95^951^15
 ;;^UTILITY(U,$J,358.3,15611,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15611,1,3,0)
 ;;=3^582.4
 ;;^UTILITY(U,$J,358.3,15611,1,4,0)
 ;;=4^NEPHRITIS,CHR RAPID PROGR
 ;;^UTILITY(U,$J,358.3,15611,2)
 ;;=^270348
 ;;^UTILITY(U,$J,358.3,15612,0)
 ;;=582.81^^95^951^10
 ;;^UTILITY(U,$J,358.3,15612,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15612,1,3,0)
 ;;=3^582.81
 ;;^UTILITY(U,$J,358.3,15612,1,4,0)
 ;;=4^NEPHRITIS,CHR IN OTH DIS
 ;;^UTILITY(U,$J,358.3,15612,2)
 ;;=^270350
 ;;^UTILITY(U,$J,358.3,15613,0)
 ;;=582.9^^95^951^13
 ;;^UTILITY(U,$J,358.3,15613,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15613,1,3,0)
 ;;=3^582.9
 ;;^UTILITY(U,$J,358.3,15613,1,4,0)
 ;;=4^NEPHRITIS,CHR NOS
 ;;^UTILITY(U,$J,358.3,15613,2)
 ;;=^270351
 ;;^UTILITY(U,$J,358.3,15614,0)
 ;;=583.81^^95^951^5
 ;;^UTILITY(U,$J,358.3,15614,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15614,1,3,0)
 ;;=3^583.81
 ;;^UTILITY(U,$J,358.3,15614,1,4,0)
 ;;=4^NEPHRITIS IN OTH DIS
 ;;^UTILITY(U,$J,358.3,15614,2)
 ;;=^82243
 ;;^UTILITY(U,$J,358.3,15615,0)
 ;;=583.81^^95^951^16
 ;;^UTILITY(U,$J,358.3,15615,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15615,1,3,0)
 ;;=3^583.81
 ;;^UTILITY(U,$J,358.3,15615,1,4,0)
 ;;=4^SECONDARY GLOMERONEPHRITIS
 ;;^UTILITY(U,$J,358.3,15615,2)
 ;;=^82243
 ;;^UTILITY(U,$J,358.3,15616,0)
 ;;=583.9^^95^951^6
 ;;^UTILITY(U,$J,358.3,15616,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15616,1,3,0)
 ;;=3^583.9
 ;;^UTILITY(U,$J,358.3,15616,1,4,0)
 ;;=4^NEPHRITIS NOS
 ;;^UTILITY(U,$J,358.3,15616,2)
 ;;=^83446
 ;;^UTILITY(U,$J,358.3,15617,0)
 ;;=710.0^^95^951^17
 ;;^UTILITY(U,$J,358.3,15617,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15617,1,3,0)
 ;;=3^710.0
 ;;^UTILITY(U,$J,358.3,15617,1,4,0)
 ;;=4^SYSTEMIC LUPUS
 ;;^UTILITY(U,$J,358.3,15617,2)
 ;;=^72159^582.81
 ;;^UTILITY(U,$J,358.3,15618,0)
 ;;=582.89^^95^952^2
 ;;^UTILITY(U,$J,358.3,15618,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15618,1,3,0)
 ;;=3^582.89
 ;;^UTILITY(U,$J,358.3,15618,1,4,0)
 ;;=4^NEPHRITIS INTERSTITIAL,CHR
 ;;^UTILITY(U,$J,358.3,15618,2)
 ;;=^270349
 ;;^UTILITY(U,$J,358.3,15619,0)
 ;;=580.89^^95^952^1
 ;;^UTILITY(U,$J,358.3,15619,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15619,1,3,0)
 ;;=3^580.89
 ;;^UTILITY(U,$J,358.3,15619,1,4,0)
 ;;=4^NEPHRITIS INTERSTITIAL,AC
 ;;^UTILITY(U,$J,358.3,15619,2)
 ;;=^270340
 ;;^UTILITY(U,$J,358.3,15620,0)
 ;;=583.89^^95^952^3
 ;;^UTILITY(U,$J,358.3,15620,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15620,1,3,0)
 ;;=3^583.89
 ;;^UTILITY(U,$J,358.3,15620,1,4,0)
 ;;=4^NEPHROPATHY,ANALGESIC
 ;;^UTILITY(U,$J,358.3,15620,2)
 ;;=^83443
 ;;^UTILITY(U,$J,358.3,15621,0)
 ;;=042.^^95^953^1
 ;;^UTILITY(U,$J,358.3,15621,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15621,1,3,0)
 ;;=3^042.
 ;;^UTILITY(U,$J,358.3,15621,1,4,0)
 ;;=4^AIDS
 ;;^UTILITY(U,$J,358.3,15621,2)
 ;;=^266500
 ;;^UTILITY(U,$J,358.3,15622,0)
 ;;=581.1^^95^953^2
 ;;^UTILITY(U,$J,358.3,15622,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15622,1,3,0)
 ;;=3^581.1
 ;;^UTILITY(U,$J,358.3,15622,1,4,0)
 ;;=4^NEPHRITIS EPIMEMBRANOUS (FSGS)
